Abstract
Background: Cataract is leading reason for blindness in all years old groups in North Africa & Middle East. Cataract was leading reason for reversible blindness worldwide between 1990 & 2010, accounting for nearly half of all cases. Most common cataract surgery method is phacoemulsification with IOL.
Aim of the Work: To assess commercially available, locally manufactured intraocular lenses Aqualens® (AH612AL) regarding quality, clinical biocompatibility and complications.
Studied cases & techniques: This prospective, interventional research involved thirty eyes with senile cataract. Patients were collected from the Ophthalmology Department, Faculty of Medicine, Al-Azhar University at time from March 2021 to March 2022.
Results: This study included thirty eyes with senile cataract operated by phaco-emulsification and implantation of IOL (Aqualens®, AH612AL). They were 11 males (36.7%) and 19 females (63.3%). The operated eyes were 16 right eye (OD) (53.3%) and 14 eyes (46.7%) were left (OS). The present research finds that there was no variation found among 48 hours and 1 week and also 1 month regarding PCO grading with p-value = 1.000 & 0.075; while there was rise in the PCO grading at 3 month and 6 months than 48 hours postoperative with p = 0.009 &
Conclusion: this research demonstrated that the optical quality of Aqualens®, AH612AL IOL has satisfactory results and significant improvement in regard to incidence of PCO formation, flare reaction, cell deposits, cystoid macular edema, aberrations, stability and visual acuity
Article Type
Original Article
Keywords
AH612AL; FDA; Pseudoexfoliation; IOLs; PMA.
Subject Area
Ophthalmology
How to Cite This Article
Elgammal, Mohamed Ahmed Hesham; Salama, Omar Hassan; and Ismail, Mahmoud Mohamed
(2023)
"Assessment of Aqualens (AH612AL) Intraocular Lens,"
Al-Azhar International Medical Journal: Vol. 4:
Iss.
8, Article 28.
DOI: https://doi.org/10.58675/2682-339X.1940
